<DOC>
	<DOC>NCT00191204</DOC>
	<brief_summary>The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.</brief_summary>
	<brief_title>Open Label Phase III Duloxetine Study for Stress Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence, Stress</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Female out patients Are ambulatory and are able to use a toilet independently and without difficulty. Use of monoamine oxidase inhibitors (MAOIs)</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>